- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03886714
Screening for Fabry Disease in Renal Transplantation (DEFYT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Exploration whether Fabry disease cases can be identified among patients who are followed at the Montpellier University Hospital after renal transplantation, with indeterminate cause of renal failure or diabetic nephropathy (due to its high frequency) or secondary focal segmental hyalinosis (FSH).
At the population level, the identification of cases at the Montpellier centre could then justify to expand this screening to other French centres. The goal is to contribute to adapt current guidelines of renal failure assessment, by systematically including Fabry among the diagnostic tests. Whether all patients with renal failure are concerned, or only those with indeterminate cause, is an important question this study will address.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Moglie Le Quintrec, Pr
- Phone Number: 0467338456
- Email: m-lequintrec-donnette@chu-montpellier.fr
Study Locations
-
-
-
Montpellier, France, 34295
- Recruiting
- UH Montpellier
-
Contact:
- MOGLIE LE QUINTREC DONNETTE, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Nephropathy of indeterminate cause, or secondary FSH or diabetic nephropathy
- Patients with kidney transplanted
- Patients still followed at the Montpellier University Hospital
- Obtaining written informed consent
- Age > 18 years old, no upper age limit
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patients with Positive screen result
Time Frame: Inclusion visit
|
The genetic analysis will be performed based on the biochemical results (low enzyme activity, raised lysoGL3)
|
Inclusion visit
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Metabolic Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Urologic Diseases
- Genetic Diseases, Inborn
- Genetic Diseases, X-Linked
- Metabolism, Inborn Errors
- Lysosomal Storage Diseases
- Lipid Metabolism Disorders
- Brain Diseases, Metabolic
- Brain Diseases, Metabolic, Inborn
- Sphingolipidoses
- Lysosomal Storage Diseases, Nervous System
- Cerebral Small Vessel Diseases
- Lipidoses
- Lipid Metabolism, Inborn Errors
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Kidney Diseases
- Fabry Disease
Other Study ID Numbers
- RECHMPL18_0015
- UF 7561 (Other Identifier: Montpellier University Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fabry Disease
-
CENTOGENE GmbH RostockCompletedFabry Disease | Anderson-Fabry Disease | Fabry´s DiseaseArgentina, Belgium, Croatia, Czechia, Denmark, France, Germany, United Kingdom
-
Wuerzburg University HospitalTakedaEnrolling by invitationLysosomal Storage Diseases | Fabry Disease | Fabry Disease, Cardiac Variant | HCM - Hypertrophic Cardiomyopathy | Anderson Fabry DiseaseGermany
-
University Hospital, RouenUnknownAnderson-Fabry DiseaseFrance
-
Amicus Therapeutics France SASActive, not recruitingFabry Disease | Anderson Fabry DiseaseFrance
-
Sangamo TherapeuticsEnrolling by invitationFabry Disease | Fabry Disease, Cardiac VariantUnited States, Australia, United Kingdom
-
University of CambridgeSanofiRecruiting
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingFabry Disease | Fabry Disease, Cardiac VariantNetherlands
-
Taipei Veterans General Hospital, TaiwanSanofiUnknownFabry Disease, Cardiac Variant
-
Shaare Zedek Medical CenterJohannes Gutenberg University MainzCompleted
-
Wolfson Medical CenterUnknownFabry Disease in the Young StrokeIsrael
Clinical Trials on Screening for Fabry disease
-
Children's Hospital of Fudan UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Wuhan Union Hospital, China and other collaboratorsWithdrawn
-
University Hospital HeidelbergCompletedFabry Disease | Chronic Abdominal Pain | Chronic Pain in the ExtremitiesGermany
-
University Hospital, AngersRecruiting
-
University Hospital, BordeauxCompletedChronic Pain | Fabry's DiseaseFrance
-
Ohio State University Comprehensive Cancer CenterCompletedCervical Carcinoma | Human Papillomavirus InfectionUnited States
-
University of ManitobaBoehringer Ingelheim; Research Manitoba; First Nations Health and Social Secretariat... and other collaboratorsNot yet recruitingKidney Disease, Chronic
-
University Hospital, BordeauxRecruitingDiabetes Mellitus, Type 2France
-
Saint Alphonsus Regional Medical CenterNot yet recruitingAtrial Fibrillation | POAF
-
Universidade do PortoHospital da Luz, Lisboa; Hospital Pedro Hispano; Centro Hospitalar de Leiria; Centro... and other collaboratorsRecruitingFabry DiseasePortugal
-
The Third Xiangya Hospital of Central South UniversitySANSURE BIOTECH INC.UnknownInfectious Disease ScreeningChina